Skip to content
healthcare.dev

SUPPRELIN LA

NDC 67979-002, histrelin acetate, implant, from Endo USA, Inc..

Product NDC
67979-002
Status
Listed
Labeler
Endo USA, Inc.
Dosage form
IMPLANT
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA022058
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/67979-002 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • HISTRELIN ACETATE50 mg/1

Pharmacologic classes

Gonadotropin Releasing Hormone Receptor Agonist [EPC]; Gonadotropin Releasing Hormone Receptor Agonists [MoA]

Package NDCNDC-11Package
67979-002-01679790002011 VIAL, GLASS in 1 CARTON (67979-002-01) / 1 IMPLANT in 1 VIAL, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/d8fb000e-3cc9-4803-b71d-2cc597661977
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=67979-002

Use it

Look up 67979-002 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/67979-002 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 67979-002. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.